Cointime

Download App
iOS & Android

YZi Labs Announces Investment in Renewal Bio, a Regenerative Medicine Company

 YZi Labs announced an investment in the regenerative medicine company Renewal Bio. This is YZi Labs' first biotechnology investment since expanding its investment scope in early 2025. Renewal Bio focuses on using its proprietary Stembroid™ platform to generate human cells and tissues that match DNA completely from the patient's own cells, aiming to address the global organ shortage crisis. This round of financing will accelerate the preclinical development of Stembroid-derived hematopoietic stem cells for the treatment of leukemia and immune diseases, and support the expansion of laboratory infrastructure.

Comments

All Comments

Recommended for you